Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments
NCT04705038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101
Last updated 2026-03-27
Summary
The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).
Conditions
Interventions
- BEHAVIORAL
-
Patient Education
Brief educational session on surgical castration as an alternative to lifelong ADT for prostate cancer.
Sponsors & Collaborators
-
University of Chicago
lead OTHER
Principal Investigators
-
Nabiel Mir, MD · University of Chicago
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-18
- Primary Completion
- 2025-04-30
- Completion
- 2025-04-30
Countries
- United States
Study Locations
More Related Trials
-
Follow-up After Surgery for Testicular Cancer
NCT05670938 ·Status: RECRUITING
-
Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer
NCT00138918 ·Status: COMPLETED ·Phase: PHASE2
-
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
NCT01620593 ·Status: COMPLETED ·Phase: PHASE2
-
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations
NCT02020876 ·Status: COMPLETED
-
Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
NCT02572934 ·Status: ACTIVE_NOT_RECRUITING
-
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
NCT01342367 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
NCT00430183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
NCT00075192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
NCT03419234 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Symptom Management, Education and Telephone Follow-up, Quality of Life,
NCT05613881 ·Status: COMPLETED ·Phase: NA
-
DeADT - Living Well With Prostate Cancer
NCT06199986 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer
NCT01084759 ·Status: COMPLETED ·Phase: NA
-
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT03436654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT01549951 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC
NCT00327340 ·Status: COMPLETED ·Phase: PHASE2
-
OGX-427 in Castration Resistant Prostate Cancer Patients
NCT01120470 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC
NCT00286793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Engaging Newly Diagnosed Men About Cancer Treatment Options
NCT02668276 ·Status: COMPLETED ·Phase: NA
-
Abiraterone Acetate for Castrate Resistant Prostate Cancer
NCT01961843 ·Status: COMPLETED ·Phase: NA
-
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
NCT04763980 ·Status: RECRUITING ·Phase: NA
-
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
NCT02380274 ·Status: COMPLETED
-
Addressing Health Literacy With a Tailored Survivorship Care Plan
NCT06674863 ·Status: RECRUITING ·Phase: NA
-
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
NCT00104715 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Feasibility Study of Mitotane in Prostate Cancer
NCT02057237 ·Status: COMPLETED ·Phase: PHASE1
-
Pioneering Advances in Care and Education (PACE)
NCT03397160 ·Status: COMPLETED ·Phase: NA